TRINITY BIOTECH MANUFACTURING SERVICES LIMITED

Trinity Biotech Manufacturing Services Limited is a publicly‑listed specialist in the development, manufacture and marketing of clinical diagnostic products. The company leverages cutting‑edge biotechnology to deliver reliable testing solutions that help hospitals, laboratories and point‑of‑care providers deliver faster, more accurate diagnoses.

Among its flagship offerings is the Premier Resolution HPLC analyser, designed for precise detection of thalassaemia and haemoglobin variants, and the Bartels® FlexTrans™ Transport Medium, which safeguards specimens against microbial contamination during transit. Trinity Biotech also supplies a single‑use immunoassay for rapid detection of HIV‑1 and HIV‑2 antibodies in serum, plasma or whole blood, and has recently secured regulatory approval for its offshored manufacturing of this rapid HIV test, as well as for the FDA‑cleared PreClara™ pre‑eclampsia service and a breakthrough continuous‑glucose‑monitoring sensor.

While its operations are global, the company’s manufacturing activities are now compliant with Nasdaq listing requirements and are based in the United States, underscoring its commitment to meeting the highest regulatory and quality standards for the international diagnostics market.